Gyre Therapeutics (GYRE) Current Taxes (2022 - 2026)
Gyre Therapeutics (GYRE) reported Current Taxes of $3.1 million for Q1 2026, up 450.26% year-over-year from $569000.0 in Q1 2025, and up 6.5% on a QoQ basis from $2.9 million in Q4 2025.
Gyre Therapeutics (GYRE) has 5 years of Current Taxes data on file, last reported at $3.1 million in Q1 2026.
- Quarterly Current Taxes rose 450.26% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 450.26% YoY) and the FY2025 annual result came in at $2.9 million, up 3.85% from the prior year.
- Current Taxes climbed to $3.1 million in Q1 2026 per GYRE's latest filing, from $2.9 million in the prior quarter.
- Across five years, Current Taxes topped out at $6.5 million in Q1 2024 and bottomed at $569000.0 in Q1 2025.
- The 5-year median for Current Taxes is $2.8 million (2024), against an average of $2.9 million.
- The widest annual swing landed in 2025, when Current Taxes plunged 91.21%; it then soared 450.26% in 2026.
- Tracing GYRE's Current Taxes over 5 years: stood at $2.1 million in 2022, then soared by 140.55% to $5.1 million in 2023, then sank by 43.98% to $2.8 million in 2024, then grew by 3.85% to $2.9 million in 2025, then climbed by 6.5% to $3.1 million in 2026.
- Per Business Quant, the three latest GYRE Current Taxes figures stand at $3.1 million (Q1 2026), $2.9 million (Q4 2025), and $2.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 569,000.00 |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 6.47 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Dec 31, 2022 | 2.10 Mn |